Questions we get asked.

Often, yes. Same-day visits are frequently available. See what to expect at your first visit. Call or text (888) 835-9995 and we'll find the soonest time available. If buprenorphine is appropriate, your prescription is sent to your pharmacy the same day.

No. This is a self-pay practice. We do not bill insurance, which allows care to be straightforward, private, and without delays from prior authorizations or network restrictions.

It can be hard to get in many places — waiting lists, prior authorizations, mandatory counseling requirements, in-person visits. None of that applies here. No referral, no insurance, no waiting list. If you call today, you can often be seen today. If buprenorphine is appropriate after your evaluation, the prescription goes to your pharmacy the same day.

Not necessarily. There are different approaches to starting buprenorphine — some traditional methods require waiting until withdrawal begins, but other approaches allow patients to start without that wait. Your physician will discuss the right induction approach for you based on your situation.

No. Because we don't bill insurance, there is no explanation of benefits sent to your employer or insurer. Your visits are protected under HIPAA and under federal confidentiality rules specific to substance use treatment. Nothing about your care is reported to your employer. What you discuss with your physician stays between you and your physician.

Yes. Your visits and records are protected under HIPAA. Because we don't bill insurance, no explanation of benefits is sent to your employer or insurer. What you discuss with your physician stays private.

That's more common than you might think — and it doesn't disqualify you from trying again. See if this is right for you. Many people who didn't do well in traditional programs do well with medication-first care. Programs that require attendance, group sessions, and compliance before prescribing create barriers that cause people to drop out. That's not a personal failure. If buprenorphine is clinically appropriate for you, we start it — without making you earn it first.

The evidence base is for buprenorphine treatment with physician oversight. That evidence is strong: reduced overdose risk, improved retention, and improved functioning over time.

The question is not whether medication works — it does. The question is how to deliver it in a way patients can stay engaged with. This approach focuses on access, continuity, and keeping patients in care.

See how buprenorphine treatment is structured →

No. Counseling is not a condition of your care here — medication is not withheld because you are not attending sessions. Federal guidance from SAMHSA and FDA specifically supports this.

That said, every visit includes time for a real conversation about where you are and what's going on. That conversation is part of the appointment — not a separate requirement.

No — and that's a deliberate choice. Every visit includes time for a clinical conversation about your goals and where you are. That conversation follows a specific, evidence-based approach. About Motivational Interviewing →

If you are looking for a practice with dedicated counseling sessions as a separate service, we are probably not the right fit — and we'll tell you that honestly.

This model works best for patients who can engage in outpatient care — for example, those who can attend visits and manage medication consistently.

For patients in more acute situations — unstable housing, active polysubstance use, or significant psychiatric instability — a higher level of care may be more appropriate. We will tell you that directly and help you find the right setting if needed.

If you need more structure — more frequent visits, more support, more accountability — we can adjust care.

If a program-based setting is a better fit, we will tell you that honestly and help you find one. This model is not the right fit for everyone.

Tell us. Some combinations — especially benzodiazepines, alcohol, and other sedatives — carry real risks alongside buprenorphine. We are not going to judge you or discharge you for being honest. We need to know what is happening to keep you safe and guide your care.

No. A positive drug screen tells us something about where you are in your treatment — it is not a reason to end your care. Drug testing is used to inform your treatment, not to penalize you. If something comes up, we talk about it. That is what a physician relationship is for.

We will work with you to reschedule. Missing a visit does not automatically put your prescription at risk. But your care depends on an ongoing relationship with your physician — staying in contact matters, and we will always work with you to make that possible.

It depends on where you are in treatment. New patients and those in early treatment are seen more frequently. Once stable, most patients are seen monthly. Visit frequency is a decision you make with your physician — there is no fixed formula. How care works →

Ask. We have a pay-what-you-can option for patients already on buprenorphine who are facing an urgent gap in care and genuinely cannot afford the standard fee. We do not want cost to be the reason someone doesn't get care. Talk to your physician about your situation.

We prescribe sublingual buprenorphine (Suboxone and Subutex) only. Sublocade and Brixadi are injectable formulations of buprenorphine — if those are the right option for you, a provider offering those formulations can help.